Maternal RSV Vaccines Show Promise for Infant Protection but Raise Safety Concerns New meta-analysis at the 2025 vaccinology conference highlights the efficacy of maternal RSV vaccines, with calls for enhanced monitoring following safety issues with one candidate

Dr. Mahmud Sheku presented a new meta-analysis at the 2025 #NFIDACVR, examining the effectiveness and safety of maternal RSV vaccines. The study highlights good infant protection and recommends future safety monitoring. #IDsky #MEDsky #PEDSsky

Listen here: www.contagionlive.com/view/materna...

🧬 From breakthrough platforms to advanced adjuvants, the future of respiratory virus #vaccines is here. Join NFID online on 5/5-7 at the 2025 #NFIDACVR for discussions on exciting new developments ...

Complimentary registration available: www.nfid.org/acvr
#IDSky #MedSky

A7: The NFID 2025 Annual Conference on Vaccinology Research is an unique online forum for discussions and interdisciplinary collaborations on the future of vaccines. Complimentary registration is available at: www.nfid.org/acvr #NFIDACVR #NPHWChat

2025 NFID Annual Conference on Vaccinology Research Call for Abstracts postcard

📣 Calling all #vaccine researchers! The call for abstracts is currently OPEN for the 2025 #NFID Annual Conference on Vaccinology Research. Share your research, learn, and collaborate with colleagues and experts in vaccinology from around the world ➡️

nfid.org/2025abstracts #NFIDACVR